Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Amanda Maxwell

London, UK

A lifetime dedicated to passionately following medtech regulations seems a big claim, but Amanda Maxwell, regulatory affairs editor, wears the badge and has a loyal list of followers. She still remains as passionate about the implications of changing requirements as 30 years ago when analysing the drafting of the first EU medical device and IVD rules. She tirelessly picks through the draft and existing requirements and the implications of the background debate, to bring you the reality of what the latest developments and discussions mean for you. Amanda knows where to get the vital information, who can offer the best inside knowledge and how to get it to readers quickly. She is well respected in the industry and has a history of moderating and chairing at many high-profile meetings in the EU and the US ( MedTech Forum (EU), AdvaMed (US), DIA (EU and US)), and a strong network of contacts among regulators, consultants, lawyers and EU institutions. She has also been active in consulting and training companies in EU medical device regulations. Amanda has been known to pick up stories while swimming in the Aegean, and there are rumours of her renting a window cleaning scaffold outside the European Commission, but she won’t comment on this and would not recommend anyone to try it!

When not writing, Amanda is a strong well-being advocate and loves health and wellness apps. She rarely sits still and loves to be out and about, actively participating in life with family and friends.

Set Alert for Articles By Amanda Maxwell

Latest From Amanda Maxwell

Italian Notified Body IMQ Is Likely To Be Next In Line For Official Designation

While the push for transparency was uppermost in the mind of the European Commission when it drafted the new Medical Device Regulation, the way we are learning about new notified bodies is far from transparent.

EU Regulation

Recruitment Focus Part 3: What Is Really Driving EU Medtech Regulatory Recruitment?

Ten key take-home messages from recent interviews with recruitment expert Elena Kyria on the impact of the new medical device regulations on recruitment in the EU. This is the third and final installment of the first part of an ongoing series of articles on this topic. The second series will begin in September. 

Medical Device Europe

DEKRA Soon To Start Transfer Of Clients To MDR And Has Priority Products

The official designation of a notified body in the European Commission’s Nando database is the trigger for that notified body to begin testing. But can manufacturers expect immediate service from DEKRA?

Medical Device Europe

Updates On The European Commission’s Medtech Agenda And Deadlines For The Rest Of 2019

The European Commission updates its rolling plan on progress with key document and structures toward implementation of the new medtech regulations every few months. What is new and what is still to come this year?

Europe Medical Device

Germany's DEKRA Named As Third MDR Notified Body In EU

Another notified body, DEKRA based in Germany, has been added to the list of MDR-accredited bodies. But time is ticking, more are urgently needed and experts are taking to social media to voice their concerns.

Europe Germany

European Commission Highlights Medtech Notified Bodies Giving It Cause For Concern

The EU notified body situation is a fluid one right now. Standards are rising, new regulations are demanding, capacity is under stress, and some notified bodies appear not to be coping in certain areas of their work.

Europe Medical Device
See All